Dyne Therapeutics Files 2024 10-K
Ticker: DYN · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1818794
| Field | Detail |
|---|---|
| Company | Dyne Therapeutics, INC. (DYN) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals, financials
TL;DR
Dyne Therapeutics filed its 2024 10-K, showing financial details and equity info.
AI Summary
Dyne Therapeutics, Inc. filed its 2024 10-K on February 27, 2025, detailing its fiscal year ending December 31, 2024. The company, focused on pharmaceutical preparations, is incorporated in Delaware and headquartered in Waltham, MA. The filing covers various financial aspects, including general and administrative expenses, and details on equity instruments like restricted stock units and stock options.
Why It Matters
This filing provides a comprehensive overview of Dyne Therapeutics' financial health and operational activities for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Dyne Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are typically detailed in a 10-K filing.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period for which the 10-K report is filed.)
- 2025-02-27 — Filing Date (The date Dyne Therapeutics submitted this 10-K to the SEC.)
Key Players & Entities
- Dyne Therapeutics, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-27 (date) — Filing date
- Waltham, MA (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- Forbion (company) — Mentioned in relation to 2024-12-31
- Atlas Venture (company) — Mentioned in relation to 2024-12-31
FAQ
What is Dyne Therapeutics' primary business focus?
Dyne Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code 2834.
When did Dyne Therapeutics' fiscal year end for this filing?
The conformed period of report for this 10-K filing is December 31, 2024.
Where is Dyne Therapeutics headquartered?
Dyne Therapeutics, Inc. is headquartered at 1560 Trapelo Road, Waltham, MA 02451.
What types of equity instruments are mentioned in the filing data?
The filing data mentions us-gaap:AccumulatedOtherComprehensiveIncomeMember, us-gaap:RestrictedStockUnitsRSUMember, us-gaap:EmployeeStockOptionMember, and us-gaap:CommonStockMember.
What is the SEC file number for Dyne Therapeutics?
The SEC file number for Dyne Therapeutics, Inc. is 001-39509.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Dyne Therapeutics, Inc. (DYN).